The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to price negotiation under the Inflation Reduction Act of 2023 (IRA) and the Act’s potential impact on profits. But an even bigger force… Continue Reading
Barely a day goes by without a headline touting how some new generative AI system will transform our lives by detecting cancer, expediting diagnosis, or helping doctors provide better care. But I’d bet my house that none of these claims… Continue Reading
Before we get to 2023, let’s talk about 2022—specifically about a technology that DIDN’T fulfill its promise last year: cryptocurrency. It was a genuinely cataclysmal year for crypto. Read crypto blogger Molly White’s jaw-dropping list for the details on just… Continue Reading
In 2005 and 2009, I published HEOR studies that led to an 80% drop in the number of US women who had their ovaries removed at the time of hysterectomy. Over the 17 years since our first paper came out,… Continue Reading
The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching. Continue Reading
